<DOC>
	<DOCNO>NCT01180647</DOCNO>
	<brief_summary>This pilot study 's primary aim compare rate sustain opioid relapse , define self-reported opioid use &gt; 50 % ( &gt; 15 30 ) day first 30 day follow release jail , among person treat XR-NTX pre-release vs. control receive XR-NTX .</brief_summary>
	<brief_title>Extended-Release Naltrexone Opioid Relapse Prevention Following Release From Jail</brief_title>
	<detailed_description>This protocol randomize person soon-to-be-released large urban jail treatment extended-release naltrexone ( XR-NTX ) , full opioid antagonist prevents activity heroin opioids . Investigators NYUSOM NYC DOHMH recruit heroin dependent person NYC jail soon-to-be-released , access opioid agonist pharmacotherapy , lower tolerance due incarceration , extremely likely relapse risk accidental overdose release . All N=40 participant receive two-session , individual psychosocial intervention , Motivational Interviewing . Half ( n=20 ) randomize pre-release treatment XR-NTX . Immediately one month follow release , participant offer continued psychosocial medication-assisted treatment ( naltrexone , buprenorphine , methadone ) Bellevue Hospital , include second XR-NTX dose among XR-NTX arm participant . The primary outcome relapse sustain opioid use first 30 day post-release . We hypothesize XR-NTX arm report significantly low rate sustain opioid relapse follow release .</detailed_description>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Analgesics , Opioid</mesh_term>
	<mesh_term>Naltrexone</mesh_term>
	<criteria>Adults incarcerate NYC jail know release date DSMIV criterion current opioid dependence No current agonist ( methadone , buprenorphine ) treatment Currently opioid free history ( 'detoxed ' ) negative urine opioids General good health determine complete medical interview physical examination Age 1860 year . History liver failure , cirrhosis , recent liver function test level great three time normal Pregnancy , lactation , plan conception Active medical illness might make participation hazardous Untreated psychiatric disorder History allergic reaction naltrexone , PLG ( polylactide coglycolide ) , carboxymethylcellulose , component diluent . Current chronic pain condition treat opioids .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Extended-release naltrexone</keyword>
	<keyword>Prisoners</keyword>
	<keyword>Opioid addiction prevention</keyword>
	<keyword>Medication Treatment Alternatives</keyword>
	<keyword>Prevention Relapse Opioid Addiction</keyword>
</DOC>